GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » Earnings per Share (Diluted)

Deltex Medical Group (LSE:DEMG) Earnings per Share (Diluted) : £-0.00 (TTM As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group Earnings per Share (Diluted)?

Deltex Medical Group's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was £0.00. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.00.

Deltex Medical Group's EPS (Basic) for the six months ended in Dec. 2023 was £0.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.00.

Deltex Medical Group's EPS without NRI for the six months ended in Dec. 2023 was £0.00. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.00.

During the past 3 years, the average EPS without NRIGrowth Rate was 20.60% per year.

During the past 13 years, Deltex Medical Group's highest 3-Year average EPS without NRI Growth Rate was 70.30% per year. The lowest was -178.10% per year. And the median was 12.60% per year.


Deltex Medical Group Earnings per Share (Diluted) Historical Data

The historical data trend for Deltex Medical Group's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group Earnings per Share (Diluted) Chart

Deltex Medical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Deltex Medical Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Deltex Medical Group's Earnings per Share (Diluted)

For the Medical Devices subindustry, Deltex Medical Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Deltex Medical Group's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's PE Ratio distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's PE Ratio falls into.



Deltex Medical Group Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Deltex Medical Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.282-0)/1181.215
=-0.00

Deltex Medical Group's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-0.745-0)/1846.653
=-0.00

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Deltex Medical Group  (LSE:DEMG) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Deltex Medical Group Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Deltex Medical Group (LSE:DEMG) Business Description

Traded in Other Exchanges
Address
Terminus Road, Chichester, W Sussex, GBR, PO19 8TX
Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (LSE:DEMG) Headlines

No Headlines